Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer

BACKGROUND: Patients with curable esophageal cancer (EC) who proceed beyond the original Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) eligibility criteria are also treated with neoadjuvant chemoradiotherapy (nCRT). This study assessed the effect that extending the CROSS...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Surg Oncol
Autori principali: de Heer, E. C., Hulshoff, J. B., Klerk, D., Burgerhof, J. G. M., de Groot, D. J. A., Plukker, J. Th. M., Hospers, G. A. P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2017
Soggetti:
Gastrointestinal Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486922/
https://ncbi.nlm.nih.gov/pubmed/28188501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-017-5797-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi